The global Head and Neck Cancer (HNC) Therapeutic market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Chemotherapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Head and Neck Cancer (HNC) Therapeutic include Eli Lilly, Sanofi, Merck & Co., Clinigen Group, Bristol-Myers Squibb, AstraZeneca, Takeda Pharmaceutical, Teva Pharmaceutical Industries and Hoffmann-La Roche, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Head and Neck Cancer (HNC) Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Head and Neck Cancer (HNC) Therapeutic. This report contains market size and forecasts of Head and Neck Cancer (HNC) Therapeutic in global, including the following market information:
Global Head and Neck Cancer (HNC) Therapeutic Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Head and Neck Cancer (HNC) Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Head and Neck Cancer (HNC) Therapeutic Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Head and Neck Cancer (HNC) Therapeutic Market Segment Percentages, by Type, 2023 (%)
Chemotherapy
Immunotherapy
Targeted Therapy
Global Head and Neck Cancer (HNC) Therapeutic Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Head and Neck Cancer (HNC) Therapeutic Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinics
Others
Global Head and Neck Cancer (HNC) Therapeutic Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Head and Neck Cancer (HNC) Therapeutic Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Head and Neck Cancer (HNC) Therapeutic revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Head and Neck Cancer (HNC) Therapeutic revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Sanofi
Merck & Co.
Clinigen Group
Bristol-Myers Squibb
AstraZeneca
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Hoffmann-La Roche
Coherus BioSciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Head and Neck Cancer (HNC) Therapeutic, market overview.
Chapter 2: Global Head and Neck Cancer (HNC) Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Head and Neck Cancer (HNC) Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Head and Neck Cancer (HNC) Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Head and Neck Cancer (HNC) Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Head and Neck Cancer (HNC) Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Head and Neck Cancer (HNC) Therapeutic Overall Market Size
2.1 Global Head and Neck Cancer (HNC) Therapeutic Market Size: 2023 VS 2030
2.2 Global Head and Neck Cancer (HNC) Therapeutic Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Head and Neck Cancer (HNC) Therapeutic Players in Global Market
3.2 Top Global Head and Neck Cancer (HNC) Therapeutic Companies Ranked by Revenue
3.3 Global Head and Neck Cancer (HNC) Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Head and Neck Cancer (HNC) Therapeutic Companies in Global Market, by Revenue in 2023
3.5 Global Companies Head and Neck Cancer (HNC) Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Head and Neck Cancer (HNC) Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Head and Neck Cancer (HNC) Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Head and Neck Cancer (HNC) Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Head and Neck Cancer (HNC) Therapeutic Market Size Markets, 2023 & 2030
4.1.2 Chemotherapy
4.1.3 Immunotherapy
4.1.4 Targeted Therapy
4.2 By Type - Global Head and Neck Cancer (HNC) Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Head and Neck Cancer (HNC) Therapeutic Revenue, 2019-2024
4.2.2 By Type - Global Head and Neck Cancer (HNC) Therapeutic Revenue, 2025-2030
4.2.3 By Type - Global Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Head and Neck Cancer (HNC) Therapeutic Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Head and Neck Cancer (HNC) Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Head and Neck Cancer (HNC) Therapeutic Revenue, 2019-2024
5.2.2 By Application - Global Head and Neck Cancer (HNC) Therapeutic Revenue, 2025-2030
5.2.3 By Application - Global Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Head and Neck Cancer (HNC) Therapeutic Market Size, 2023 & 2030
6.2 By Region - Global Head and Neck Cancer (HNC) Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Head and Neck Cancer (HNC) Therapeutic Revenue, 2019-2024
6.2.2 By Region - Global Head and Neck Cancer (HNC) Therapeutic Revenue, 2025-2030
6.2.3 By Region - Global Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Head and Neck Cancer (HNC) Therapeutic Revenue, 2019-2030
6.3.2 US Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.3.3 Canada Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.3.4 Mexico Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Head and Neck Cancer (HNC) Therapeutic Revenue, 2019-2030
6.4.2 Germany Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.4.3 France Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.4.4 U.K. Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.4.5 Italy Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.4.6 Russia Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.4.7 Nordic Countries Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.4.8 Benelux Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Head and Neck Cancer (HNC) Therapeutic Revenue, 2019-2030
6.5.2 China Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.5.3 Japan Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.5.4 South Korea Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.5.5 Southeast Asia Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.5.6 India Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Head and Neck Cancer (HNC) Therapeutic Revenue, 2019-2030
6.6.2 Brazil Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.6.3 Argentina Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Head and Neck Cancer (HNC) Therapeutic Revenue, 2019-2030
6.7.2 Turkey Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.7.3 Israel Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.7.4 Saudi Arabia Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
6.7.5 UAE Head and Neck Cancer (HNC) Therapeutic Market Size, 2019-2030
7 Head and Neck Cancer (HNC) Therapeutic Companies Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Head and Neck Cancer (HNC) Therapeutic Major Product Offerings
7.1.4 Eli Lilly Head and Neck Cancer (HNC) Therapeutic Revenue in Global Market (2019-2024)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Head and Neck Cancer (HNC) Therapeutic Major Product Offerings
7.2.4 Sanofi Head and Neck Cancer (HNC) Therapeutic Revenue in Global Market (2019-2024)
7.2.5 Sanofi Key News & Latest Developments
7.3 Merck & Co.
7.3.1 Merck & Co. Company Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Head and Neck Cancer (HNC) Therapeutic Major Product Offerings
7.3.4 Merck & Co. Head and Neck Cancer (HNC) Therapeutic Revenue in Global Market (2019-2024)
7.3.5 Merck & Co. Key News & Latest Developments
7.4 Clinigen Group
7.4.1 Clinigen Group Company Summary
7.4.2 Clinigen Group Business Overview
7.4.3 Clinigen Group Head and Neck Cancer (HNC) Therapeutic Major Product Offerings
7.4.4 Clinigen Group Head and Neck Cancer (HNC) Therapeutic Revenue in Global Market (2019-2024)
7.4.5 Clinigen Group Key News & Latest Developments
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Head and Neck Cancer (HNC) Therapeutic Major Product Offerings
7.5.4 Bristol-Myers Squibb Head and Neck Cancer (HNC) Therapeutic Revenue in Global Market (2019-2024)
7.5.5 Bristol-Myers Squibb Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Head and Neck Cancer (HNC) Therapeutic Major Product Offerings
7.6.4 AstraZeneca Head and Neck Cancer (HNC) Therapeutic Revenue in Global Market (2019-2024)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Company Summary
7.7.2 Takeda Pharmaceutical Business Overview
7.7.3 Takeda Pharmaceutical Head and Neck Cancer (HNC) Therapeutic Major Product Offerings
7.7.4 Takeda Pharmaceutical Head and Neck Cancer (HNC) Therapeutic Revenue in Global Market (2019-2024)
7.7.5 Takeda Pharmaceutical Key News & Latest Developments
7.8 Teva Pharmaceutical Industries
7.8.1 Teva Pharmaceutical Industries Company Summary
7.8.2 Teva Pharmaceutical Industries Business Overview
7.8.3 Teva Pharmaceutical Industries Head and Neck Cancer (HNC) Therapeutic Major Product Offerings
7.8.4 Teva Pharmaceutical Industries Head and Neck Cancer (HNC) Therapeutic Revenue in Global Market (2019-2024)
7.8.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.9 Hoffmann-La Roche
7.9.1 Hoffmann-La Roche Company Summary
7.9.2 Hoffmann-La Roche Business Overview
7.9.3 Hoffmann-La Roche Head and Neck Cancer (HNC) Therapeutic Major Product Offerings
7.9.4 Hoffmann-La Roche Head and Neck Cancer (HNC) Therapeutic Revenue in Global Market (2019-2024)
7.9.5 Hoffmann-La Roche Key News & Latest Developments
7.10 Coherus BioSciences
7.10.1 Coherus BioSciences Company Summary
7.10.2 Coherus BioSciences Business Overview
7.10.3 Coherus BioSciences Head and Neck Cancer (HNC) Therapeutic Major Product Offerings
7.10.4 Coherus BioSciences Head and Neck Cancer (HNC) Therapeutic Revenue in Global Market (2019-2024)
7.10.5 Coherus BioSciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Head and Neck Cancer (HNC) Therapeutic Market Opportunities & Trends in Global Market
Table 2. Head and Neck Cancer (HNC) Therapeutic Market Drivers in Global Market
Table 3. Head and Neck Cancer (HNC) Therapeutic Market Restraints in Global Market
Table 4. Key Players of Head and Neck Cancer (HNC) Therapeutic in Global Market
Table 5. Top Head and Neck Cancer (HNC) Therapeutic Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Head and Neck Cancer (HNC) Therapeutic Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Head and Neck Cancer (HNC) Therapeutic Revenue Share by Companies, 2019-2024
Table 8. Global Companies Head and Neck Cancer (HNC) Therapeutic Product Type
Table 9. List of Global Tier 1 Head and Neck Cancer (HNC) Therapeutic Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Head and Neck Cancer (HNC) Therapeutic Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Head and Neck Cancer (HNC) Therapeutic Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Head and Neck Cancer (HNC) Therapeutic Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Head and Neck Cancer (HNC) Therapeutic Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Head and Neck Cancer (HNC) Therapeutic Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2025-2030
Table 30. Eli Lilly Company Summary
Table 31. Eli Lilly Head and Neck Cancer (HNC) Therapeutic Product Offerings
Table 32. Eli Lilly Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn) & (2019-2024)
Table 33. Eli Lilly Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Head and Neck Cancer (HNC) Therapeutic Product Offerings
Table 36. Sanofi Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn) & (2019-2024)
Table 37. Sanofi Key News & Latest Developments
Table 38. Merck & Co. Company Summary
Table 39. Merck & Co. Head and Neck Cancer (HNC) Therapeutic Product Offerings
Table 40. Merck & Co. Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn) & (2019-2024)
Table 41. Merck & Co. Key News & Latest Developments
Table 42. Clinigen Group Company Summary
Table 43. Clinigen Group Head and Neck Cancer (HNC) Therapeutic Product Offerings
Table 44. Clinigen Group Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn) & (2019-2024)
Table 45. Clinigen Group Key News & Latest Developments
Table 46. Bristol-Myers Squibb Company Summary
Table 47. Bristol-Myers Squibb Head and Neck Cancer (HNC) Therapeutic Product Offerings
Table 48. Bristol-Myers Squibb Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn) & (2019-2024)
Table 49. Bristol-Myers Squibb Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Head and Neck Cancer (HNC) Therapeutic Product Offerings
Table 52. AstraZeneca Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn) & (2019-2024)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Takeda Pharmaceutical Company Summary
Table 55. Takeda Pharmaceutical Head and Neck Cancer (HNC) Therapeutic Product Offerings
Table 56. Takeda Pharmaceutical Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn) & (2019-2024)
Table 57. Takeda Pharmaceutical Key News & Latest Developments
Table 58. Teva Pharmaceutical Industries Company Summary
Table 59. Teva Pharmaceutical Industries Head and Neck Cancer (HNC) Therapeutic Product Offerings
Table 60. Teva Pharmaceutical Industries Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn) & (2019-2024)
Table 61. Teva Pharmaceutical Industries Key News & Latest Developments
Table 62. Hoffmann-La Roche Company Summary
Table 63. Hoffmann-La Roche Head and Neck Cancer (HNC) Therapeutic Product Offerings
Table 64. Hoffmann-La Roche Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn) & (2019-2024)
Table 65. Hoffmann-La Roche Key News & Latest Developments
Table 66. Coherus BioSciences Company Summary
Table 67. Coherus BioSciences Head and Neck Cancer (HNC) Therapeutic Product Offerings
Table 68. Coherus BioSciences Head and Neck Cancer (HNC) Therapeutic Revenue (US$, Mn) & (2019-2024)
Table 69. Coherus BioSciences Key News & Latest Developments
List of Figures
Figure 1. Head and Neck Cancer (HNC) Therapeutic Segment by Type in 2023
Figure 2. Head and Neck Cancer (HNC) Therapeutic Segment by Application in 2023
Figure 3. Global Head and Neck Cancer (HNC) Therapeutic Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Head and Neck Cancer (HNC) Therapeutic Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Head and Neck Cancer (HNC) Therapeutic Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Head and Neck Cancer (HNC) Therapeutic Revenue in 2023
Figure 8. By Type - Global Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
Figure 9. By Application - Global Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
Figure 10. By Type - Global Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
Figure 12. By Application - Global Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
Figure 14. By Region - Global Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
Figure 15. By Country - North America Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
Figure 16. US Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
Figure 20. Germany Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 21. France Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
Figure 28. China Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 32. India Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
Figure 34. Brazil Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Head and Neck Cancer (HNC) Therapeutic Revenue Market Share, 2019-2030
Figure 37. Turkey Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Head and Neck Cancer (HNC) Therapeutic Revenue, (US$, Mn), 2019-2030
Figure 41. Eli Lilly Head and Neck Cancer (HNC) Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Sanofi Head and Neck Cancer (HNC) Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Merck & Co. Head and Neck Cancer (HNC) Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Clinigen Group Head and Neck Cancer (HNC) Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Bristol-Myers Squibb Head and Neck Cancer (HNC) Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. AstraZeneca Head and Neck Cancer (HNC) Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Takeda Pharmaceutical Head and Neck Cancer (HNC) Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Teva Pharmaceutical Industries Head and Neck Cancer (HNC) Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Hoffmann-La Roche Head and Neck Cancer (HNC) Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Coherus BioSciences Head and Neck Cancer (HNC) Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
